Show simple item record

dc.contributor.authorGomez-Peralta, Fernando
dc.contributor.authorAbreu, Cristina
dc.contributor.authorLecube Torelló, Albert
dc.contributor.authorBellido, Diego
dc.contributor.authorSoto, Alfonso
dc.contributor.authorMorales, Cristóbal
dc.contributor.authorBrito-Sanfiel, Miguel
dc.contributor.authorUmpierrez, Guillermo
dc.date.accessioned2017-11-20T11:16:18Z
dc.date.available2017-11-20T11:16:18Z
dc.date.issued2017
dc.identifier.issn1869-6953
dc.identifier.urihttp://hdl.handle.net/10459.1/60513
dc.description.abstractErratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetes.ca_ES
dc.language.isoengca_ES
dc.publisherSpringer Verlagca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1007/s13300-017-0290-3ca_ES
dc.relation.ispartofDiabetes Therapy, 2017, vol. 8, núm. 5, p. 963-965ca_ES
dc.rightscc-by-nc (c) Gomez-Peralta et al., 2017ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.titleErratum to: practical approach to initiating SGLT2 inhibitors in type 2 diabetesca_ES
dc.typearticleca_ES
dc.type.versionpublishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.1007/s13300-017-0290-3


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by-nc (c) Gomez-Peralta et al., 2017
Except where otherwise noted, this item's license is described as cc-by-nc (c) Gomez-Peralta et al., 2017